Athira Pharma

IPO

LeonaBio

Bothell, United States · Founded 2011 · $85.0M raised

Employees
11–50
Founded
2011
Business Model
B2B
Website
athira.com
Total Funding
$85.0M
Last Round
$85.0M Series BJun 2020
Rounds
1

About

Athira Pharma develops novel small-molecule therapies for people who need better treatment options. Its lead drug candidates, lasofoxifene and brelgometon (ATH-1105), are intended to address devastating diseases where current options are limited. The company runs clinical trials to evaluate the safety and efficacy of these product candidates and to advance its mission of providing better care through research and product development.

Summary

Athira Pharma is a Biotech company based in Bothell, United States, founded in 2011. It has raised $85.0M in total across 1 round, most recently a $85.0M Series B round in Jun 2020. Investors include Perceptive Advisors and RTW Investments.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOOct 2020
$204.0M

Sign up to see all 2 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Athira Pharma on Indexed.vc
<a href="https://indexed.vc/companies/athira-pharma"><img src="https://indexed.vc/api/badge/company/athira-pharma" alt="Athira Pharma on Indexed.vc" width="260" height="76" /></a>